WO2016153144A1 - Oral composition effective in inhibiting calculus formation - Google Patents

Oral composition effective in inhibiting calculus formation Download PDF

Info

Publication number
WO2016153144A1
WO2016153144A1 PCT/KR2015/012470 KR2015012470W WO2016153144A1 WO 2016153144 A1 WO2016153144 A1 WO 2016153144A1 KR 2015012470 W KR2015012470 W KR 2015012470W WO 2016153144 A1 WO2016153144 A1 WO 2016153144A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
metal ion
cationic polymer
oral
anionic metal
Prior art date
Application number
PCT/KR2015/012470
Other languages
French (fr)
Korean (ko)
Inventor
김찬호
이현기
변경희
박상철
이병렬
김기정
김유진
김대경
Original Assignee
주식회사 아모레퍼시픽
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 아모레퍼시픽 filed Critical 주식회사 아모레퍼시픽
Priority to CN201580075837.5A priority Critical patent/CN107205892B/en
Priority claimed from KR1020150162289A external-priority patent/KR102406001B1/en
Publication of WO2016153144A1 publication Critical patent/WO2016153144A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41Amines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Definitions

  • the present invention relates to an oral composition for inhibiting tartar formation containing an anionic metal ion sequestrant and a cationic polymer. More specifically, the phosphate anionic metal ion sequestrant and a polyquaternium cationic polymer are used to treat coacetate.
  • the present invention relates to a composition for oral cavity which is adhered to the tooth surface to form an anionic metal ion sequestrant that inhibits tartar formation and remains in the oral cavity even after rinsing.
  • oral diseases are caused by various bacteria living in the oral cavity, and harmful oral bacteria eat and remnant such as food from the obtained film to proliferate to form plaques, and plaques are metal ions such as calcium and magnesium in saliva or blood. In combination with calcified calculus.
  • plaque and tartar cause gum diseases such as gingivitis and periodontitis, and further damage the teeth.
  • Regular brushing helps prevent the rapid formation of these deposits, but even regular brushing is not enough to remove all the stone deposits attached to the teeth. Therefore, in order to suppress plaque and tartar formation, an abrasive is physically used, and an antibacterial agent and a metal ion blocking agent are used chemically.
  • Abrasives used in oral products include polymer materials such as calcium carbonate, silica, aluminum hydroxide, calcium phosphate, baking soda, polyethylene and polyvinyl chloride, and antibacterial agents used in oral products include cetylpyridinium chloride and hexahalonium chloride.
  • Benzalkonium chloride, decarinium chloride, chlorohexidine, triclosan, thymol, isopropylmethylphenol and alkyldiaminoethylglycolic acid, and metal ion sequestrants include pyrophosphate, polyphosphate and polyphosphate. Phosphates and the like.
  • metal ion sequestrants have been mainly used to suppress tartar formation, but when the metal ion sequestrants are used alone, they do not remain in the oral cavity when brushing and rinsing. In addition, when an excessive amount of the metal ion blocking agent is added to increase the removal efficiency of tartar, irritation may occur, and the usability may be deteriorated due to inferior taste.
  • the present inventors have made diligent efforts to find a method for retaining the metal ion sequestrant in the oral cavity even after rinsing the toothpaste, resulting in the composition of the oral composition containing a cationic polymer together with the existing anionic metal ion sequestrant.
  • the coacervate is formed by the precipitation reaction of the anion and the cation to confirm that it is effective in inhibiting tartar formation by leaving a larger amount of anionic metal ion blocker in the teeth, to complete the present invention.
  • An object of the present invention is to provide an oral composition which contains an anionic metal ion sequestrant and a cationic polymer to induce coacervation thereof, thereby inhibiting tartar formation by remaining an anionic metal ion sequestrant on the tooth surface.
  • the present invention provides an oral composition for inhibiting tartar formation containing an anionic metal ion sequestrant and a cationic polymer as an active ingredient.
  • Oral composition for inhibiting tartar formation of the present invention can effectively prevent tartar formation on the surface of the tooth, and at the same time maintain the flavor of the toothpaste and improve the foaming force.
  • the anionic metal ion sequestrant and the cationic polymer remained on the tooth surface in the form of coacetate. As a result, it was confirmed that the remaining anionic metal ion blocking agent exhibits an effect of suppressing tartar formation.
  • the present invention relates to an oral composition for inhibiting tartar formation containing an anionic metal ion sequestrant and a cationic polymer as an active ingredient, and the anionic metal ion sequestrant and the cationic polymer react with each other. It can be characterized in that to form coacervate on the tooth surface.
  • the composition may be characterized in that it further contains a surfactant.
  • Coacervation refers to a phenomenon in which a colloidal sol concentrated in a dispersion medium is separated from a hydrophilic colloidal solution by a decrease in hydration of the colloidal particles and an electrostatic factor. The colloid concentration is high and the other liquid phase is lower in the colloid concentration.
  • Coacervate refers to a colloidal material formed due to coacervation phenomena when anionic polymer electrolyte and cationic polymer electrolyte are mixed under certain conditions.
  • the anionic metal ion sequestrant contained in the composition for oral cavity of the present invention forms coacervates by ionic bonding with the cationic polymer to precipitate, and the formed coacervates may have a metal ion sequestrant having an effect of inhibiting tartar formation on the tooth surface for a long time.
  • the anionic metal ion blocking agent may be characterized in that the phosphate compound.
  • Anionic metal ion sequestrant is a substance that inhibits tartar formation by chelating metal ions which have an important effect on tartar formation.
  • Phosphoric acid-based compounds are preferred, and hexametaphosphate and pyrophosphate.
  • Polyphosphate, and salts thereof may be one or more selected from the group consisting of.
  • the salt may be in the form of a combination of 1 to 4 alkali metal cations and an anionic phosphate-based compound, and specific examples thereof include sodium phosphate, monosodium phosphate, disodium phosphate, and tree.
  • the cationic polymer may be a polyquaternium-based compound.
  • the polyquaternium-based compound refers to a polymer compound (polymer) in which quaternary ammonium ions are present at the center, and preferably one selected from the group consisting of polyquaternium-10, polyquaternium-6, and polyquaternium-11 It may be more than, but is not necessarily limited thereto.
  • the composition for oral cavity may further comprise a surfactant, in addition to the anionic metal ion blocking agent and the cationic polymer.
  • a surfactant include anionic surfactants such as glycinate, sulfate, sulfosuccinate, sacosinate, phosphate, isethionate, glutamate, and taurate, and betaine.
  • Amphoteric surfactants such as, steine, ampoacetate, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene (cured) castor oil, glycerin fatty acid ester, sorbitan fatty acid ester, sucrose fatty acid ester, alkylolamide, alkylglucose
  • Nonionic surfactants such as seeds, cationic surfactants such as N-alkyldiamino ethylglycine, and the like, preferably sodium lauryl sulfate and sodium methyl cocoyl taurate , And disodium lauryl sulfosuccinate, but may be one or more selected from the group consisting of It is not limited to this.
  • the anionic metal ion sequestrant may be contained in 0.1 to 10.0% by weight relative to the total weight of the composition, preferably 1.0 to 7.0% by weight, more preferably 3.0 to 5.0% by weight It may be contained. If the content of the anionic metal ion blocker is less than 0.1% by weight, no coacervate is formed. If the content of the anionic metal ion blocker is greater than 10.0% by weight, the flavor and foaming power may be lowered and the irritation may be increased. have.
  • the cationic polymer may be contained in an amount of 0.01 to 0.50% by weight based on the total weight of the composition, preferably 0.05 to 0.50% by weight, more preferably 0.10 to 0.50% by weight. If the content of the cationic polymer is less than 0.01% by weight coacetate is not formed, if the content exceeds 0.50% by weight it may be inconvenient to use the high viscosity in the toothpaste.
  • the anionic metal ion blocking agent and the cationic polymer may be mixed and contained in a weight ratio of 0.2: 1 to 1000: 1, preferably 10: 1 to 100: 1, more preferably May be mixed in a weight ratio of 30: 1 to 50: 1. Since the molecular weight of the anionic metal ion blocking agent is relatively small, it is preferable to mix at a higher ratio than the cationic polymer. If the mixing ratio of the anionic metal ion blocking agent and the cationic polymer is less than 0.2: 1 or more than 1000: 1, coacervate may be difficult to form.
  • composition for oral cavity of this invention is not specifically limited in the formulation, For example, Toothpaste, Oral detergent, Oral detergent, Chewing gum, Candy, Oral spray, Oral toothpaste, A tooth whitening agent, etc. can be provided. .
  • composition for oral cavity of the present invention may contain abrasives, wetting agents, auxiliary foaming agents, binders, sweeteners, pH adjusting agents, preservatives, active ingredients, fragrances, brighteners, pigments, solvents and the like which are commonly used according to the formulation and purpose of use. .
  • abrasive precipitated silica, silica gel, zirconium silicate, calcium monohydrogen phosphate, calcium monohydrogen phosphate, hydrous alumina, hard calcium carbonate, heavy calcium carbonate, calcium pyrophosphate, insoluble methphosphate, aluminum silicate and the like can be used.
  • wetting agent concentrated glycerin, glycerin, aqueous sorbitol solution, amorphous sorbitol aqueous solution, polyethylene glycols, propylene glycol and the like can be used.
  • anionic and nonionic surfactants such as sodium alkyl sulfate, sodium lauryl sulfate, sucrose fatty acid ester, and sorbitan fatty acid ester may be used.
  • the binder is sodium carboxymethyl cellulose, carrageenan, xanthan gum, hydroxyethyl cellulose, hydroxypropylmethylcellulose, hydroxypropyl cellulose, guar gum, gellan gum, carbomer, pectin, polyvinylpyrrolidone, carboxyvinyl polymer Sodium alginate, laponite, sodium carboxymethylcellulose, xanthan gum and the like can be used.
  • sweetener examples include saccharin sodium, sucralose, maltitol, aspartame, erythritol, xylitol, licorice acid, saccharin, and the like.
  • the preservatives include benzoic acid, methylparaben, propylparaben, sodium benzoate, paraoxybenzoic acid ester, and the like.
  • the fragrance may be used alone or mixed with peppermint oil, spearmint oil, menthol, etc.
  • the pH adjuster may be used sodium phosphate, disodium phosphate, citric acid, triethanolamine and the like.
  • purified water in order to test the degree of coacervate formation and residual degree of the oral composition of the present invention, purified water, anionic metal ion blocker (sodium hexametaphosphate, tetrasodium pyrophosphate, sodium tripolyphosphate), cationic polymer (polyquaternium -10, polyquaternium-6, polyquaternium-11), surfactant (sodium lauryl sulfate, sodium methyl cocoyl taurate, dissonium lauryl sulfosuccinate) as the main components, Examples 1 to 9, and Comparative Examples 1 to 3, respectively, were prepared to have a total weight of 100 g as in the configuration.
  • anionic metal ion blocker sodium hexametaphosphate, tetrasodium pyrophosphate, sodium tripolyphosphate
  • cationic polymer polyquaternium -10, polyquaternium-6, polyquaternium-11
  • surfactant sodium lauryl sulfate, sodium
  • Example 4 Example 5
  • Example 6 Example 7
  • Example 8 Example 9 Purified water To 100 To 100 To 100 To100 To100 To100 To100 To100 To100 To100 To100 Sodium hexametaphosphate 3 0.5 7 3 3 - - 3 3 3 5 Tetrasodium pyrophosphate - - - - - 3 - - - - - - - Sodium tripolyphosphate - - - - - - - - - Polyquaternium-10 - 0.1 0.1 0.1 0.1 0.1 - - 0.1 0.1 0.1 - - 0.1 0.1 0.1 Polyquaternium-6 - - - - - - - - - - - Polyquaternium-11 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
  • Example 1 containing a cationic polymer together with an anionic metal ion sequestrant, but no surfactant.
  • the dilution conditions showed a difference in the degree of coacervate production.
  • the solution containing the anionic metal ion sequestrant, the cationic polymer, and the surfactant was diluted, more coacetate was formed, and it was confirmed that coacervate was not formed again after a certain point. From this, it could be confirmed that the proper dilution ratio is important for coacervate formation.
  • the type of cationic polymer (compare Examples 2, 5, 6), anionic It was confirmed that there was a difference in the degree of coacervate production depending on the type of the metal ion blocking agent (compare Examples 2, 3, 4) or the type of the surfactant (compare Examples 2, 7, 8), and anionic metal ion According to the content of the blocking agent (compare Examples 2, 9) it was confirmed that the difference in the degree of coacetate production.
  • the mixing ratio (weight ratio) of the anionic metal ion sequestering agent and the cationic polymer is 30: 1 in Comparative Example 2 lower than 30: 1, or in Comparative Example 3 higher than 50: 1, It was found that coacervates were not produced well compared to Examples 1 to 9 in the range of ⁇ 50: 1.
  • Example 1 after confirming that coacervate is formed in a solution containing an anionic metal ion sequestrant, a cationic polymer, and a surfactant, an in vitro test is performed to determine how much coacervate formed remains on the tooth surface. Measured through.
  • V-8 cross brushing machine which is an automatic brushing machine on hydroxyapatite disk (Clarkson Chromatography Products) Brushing was performed using (V-8 Cross Brushing Machine®, Sabri, USA). Four disks were used to reduce the error between the hydroxyapatite disks, and the diluted solution was brushed with a brushing machine for 5 minutes, and then washed five times.
  • Examples 10 to 11 and Comparative Example 4 in which a coacervate solution containing an anionic metal ion blocking agent and a cationic polymer were included in a paste formulation in the form of a toothpaste were prepared as shown in Table 4 below.
  • Example 11 solvent Purified water To 100 To 100 To 100 Metal Ion Blocker Sodium hexametaphosphate 3 3 5 Cationic polymer Polyquaternium-10 - 0.1 0.1 Active ingredient Sodium monofluorophosphate 0.76 0.76 0.76 Humectant Sorbitol Liquid (70%) 50 50 50 Sweetener Sodium saccharin 0.4 0.4 0.4 abrasive Silica 10 10 10 Thickener Hydroxymethylcellulose 1.5 1.5 1.5 Spices Combination spices One One One Foam Sodium lauryl sulfate 2 2 2 2 2 2
  • the sanded glass rod was immersed in a solution added with saliva and sugar obtained from the panel, and then aged at 35 degrees for 2 days. After forming plaque on the surface of the glass rod, the glass rod was immersed in a crystallization solution consisting of 25% toothpaste slurry solution (Comparative Examples 4, 10 and 11) and calcium chloride (1.5 mM) and stored overnight for 5 seconds. After washing the glass rod, it was stored again in the toothpaste slurry solution and crystallization solution. The tartar formed by repeating this for two weeks was dissolved in strong acid (1M HCl) and strong base (1M KOH) and analyzed by calcium content using ion chromatography (Ion chromatography, Metrohm). The results are shown in Table 5 below. It was judged that the lower the calcium content, the better the ability to inhibit tartar formation.
  • Example 10 Based on the measurement results of calculus formation inhibitory power of Test Example 3, the feeling of use of the toothpaste was evaluated.
  • Example 10, Example 11, and Comparative Example 4 were used by 20 people, and after two weeks of use, a survey was conducted to evaluate flavor, foaming power, stimulus, and overall satisfaction, and the results are shown in Table 6 below. Indicated.
  • Example 10 Flavor 3.5 3.3 3.6 Bubble 3.7 4.2 4.0 Irritation 4.0 3.9 3.9 Total satisfaction 3.5 3.7 3.6
  • composition containing the cationic polymer did not significantly affect the flavor and irritation of the toothpaste, and rather helped in foaming power.

Abstract

The present invention relates to an oral composition for inhibiting calculus formation, containing an anionic sequestering agent and a cationic polymer and, more specifically, to an oral composition in which a phosphate-based anionic sequestering agent and a polyquaternium-based cationic polymer form a coacervate during teeth brushing such that the coacervate adheres to the surface of the teeth, thereby allowing the anionic sequestering agent, which is an ingredient inhibiting calculus formation, to remain in the mouth for a long time even after rinsing. The oral composition for inhibiting calculus formation, of the present invention, can effectively prevent calculus formation on the surface of teeth and can simultaneously improve foaming power while maintaining the flavor of a toothpaste.

Description

치석 형성 억제에 효과적인 구강용 조성물Oral composition effective for inhibiting tartar formation
본 발명은 음이온성 금속이온봉쇄제와 양이온성 고분자를 함유하는 치석 형성 억제용 구강용 조성물에 관한 것으로, 보다 구체적으로는 양치 과정 중에 포스페이트계 음이온 금속이온봉쇄제와 폴리쿼터늄계 양이온 고분자가 코아세르베이트를 형성함으로써 치아 표면에 부착되어 치석형성 억제성분인 음이온계 금속이온봉쇄제가 헹굼 후에도 구강 내에 오랫동안 잔류하도록 하는 구강용 조성물에 관한 것이다.The present invention relates to an oral composition for inhibiting tartar formation containing an anionic metal ion sequestrant and a cationic polymer. More specifically, the phosphate anionic metal ion sequestrant and a polyquaternium cationic polymer are used to treat coacetate. The present invention relates to a composition for oral cavity which is adhered to the tooth surface to form an anionic metal ion sequestrant that inhibits tartar formation and remains in the oral cavity even after rinsing.
일반적으로 구강 질환은 구강에 살고 있는 각종 세균들에 의해 발생하며, 유해 구강 세균들이 획득 피막에서 음식물 등의 잔유물을 먹고 증식하여 프라그를 형성하고, 프라그는 타액이나 혈액내의 칼슘 및 마그네슘 등의 금속 이온과 결합하여 석회화된 치석을 형성하게 된다. 이러한 프라그와 치석은 치은염, 치주염 등과 같은 잇몸질환을 일으키며, 더 나아가 치아에 손상을 주게 된다. 규칙적인 칫솔질은 이들 침착물의 빠른 형성을 막는데 도움을 주지만, 규칙적인 칫솔질조차도 치아에 부착된 모든 결석 침착물을 제거하기에는 충분하지 않다. 그래서 프라그와 치석 형성 억제를 위해 물리적으로는 연마제를 사용하고 화학적으로는 항균제 및 금속이온봉쇄제를 사용한다. In general, oral diseases are caused by various bacteria living in the oral cavity, and harmful oral bacteria eat and remnant such as food from the obtained film to proliferate to form plaques, and plaques are metal ions such as calcium and magnesium in saliva or blood. In combination with calcified calculus. Such plaque and tartar cause gum diseases such as gingivitis and periodontitis, and further damage the teeth. Regular brushing helps prevent the rapid formation of these deposits, but even regular brushing is not enough to remove all the stone deposits attached to the teeth. Therefore, in order to suppress plaque and tartar formation, an abrasive is physically used, and an antibacterial agent and a metal ion blocking agent are used chemically.
구강용 제품에 사용되는 연마제에는 탄산칼슘, 실리카, 수산화알루미늄, 인산칼슘, 베이킹소다, 폴리에칠렌 및 폴리염화비닐 등과 같은 고분자물질이 있고, 구강용 제품에 사용되는 항균제에는 염화세틸피리디늄, 염화헥살코늄, 염화벤잘코니움, 염화데카리늄, 클로로헥시딘, 트리클로산, 티몰, 이소프로필메칠페놀 및 염화알킬디아미노에칠글리산 등이 있으며, 금속이온봉쇄제로는 파이로포스페이트, 폴리포스페이트 및 폴리포스포네이트 등이 있다.Abrasives used in oral products include polymer materials such as calcium carbonate, silica, aluminum hydroxide, calcium phosphate, baking soda, polyethylene and polyvinyl chloride, and antibacterial agents used in oral products include cetylpyridinium chloride and hexahalonium chloride. , Benzalkonium chloride, decarinium chloride, chlorohexidine, triclosan, thymol, isopropylmethylphenol and alkyldiaminoethylglycolic acid, and metal ion sequestrants include pyrophosphate, polyphosphate and polyphosphate. Phosphates and the like.
위와 같이 치석 형성 억제를 위해 주로 금속이온봉쇄제가 사용되어 왔으나, 금속이온봉쇄제가 단독으로 사용될 경우에는 양치질을 하고 헹구면 구강에 잔류하지 않고 씻겨나가 치석 형성 억제 효능에 어느 정도 한계가 있었다. 또한, 치석 제거 효능을 높이기 위해 금속이온봉쇄제를 과량 첨가하였을 경우, 자극이 생길 수 있으며, 역한 맛 등으로 인해 사용감이 나빠질 수도 있다. As described above, metal ion sequestrants have been mainly used to suppress tartar formation, but when the metal ion sequestrants are used alone, they do not remain in the oral cavity when brushing and rinsing. In addition, when an excessive amount of the metal ion blocking agent is added to increase the removal efficiency of tartar, irritation may occur, and the usability may be deteriorated due to inferior taste.
이에, 본 발명자들은 치약을 헹궈낸 후에도 금속이온봉쇄제를 구강 내에 오래 잔류시키기 위한 방법을 찾기 위하여 예의 노력한 결과, 기존의 음이온성 금속이온봉쇄제와 함께 양이온성 고분자를 함께 함유하는 구강용 조성물의 경우, 음이온과 양이온의 침전반응으로 코아세르베이트가 형성되어 치아에 더 많은 양의 음이온계 금속이온봉쇄제를 잔류시켜 치석 형성 억제에 효과적임을 확인하고, 본 발명을 완성하게 되었다.Accordingly, the present inventors have made diligent efforts to find a method for retaining the metal ion sequestrant in the oral cavity even after rinsing the toothpaste, resulting in the composition of the oral composition containing a cationic polymer together with the existing anionic metal ion sequestrant. In this case, the coacervate is formed by the precipitation reaction of the anion and the cation to confirm that it is effective in inhibiting tartar formation by leaving a larger amount of anionic metal ion blocker in the teeth, to complete the present invention.
본 발명의 목적은 음이온성 금속이온봉쇄제 및 양이온성 고분자를 함유함으로써 이들의 코아세르베이션을 유도하고, 이로 인하여 음이온성 금속이온봉쇄제가 치아 표면에 잔류함으로써 치석 형성을 억제시키는 구강용 조성물을 제공하는 데 있다.SUMMARY OF THE INVENTION An object of the present invention is to provide an oral composition which contains an anionic metal ion sequestrant and a cationic polymer to induce coacervation thereof, thereby inhibiting tartar formation by remaining an anionic metal ion sequestrant on the tooth surface. There is.
상기 목적을 달성하기 위하여, 본 발명은 음이온성 금속이온봉쇄제 및 양이온성 고분자를 유효성분으로 함유하는 치석 형성 억제용 구강용 조성물을 제공한다.In order to achieve the above object, the present invention provides an oral composition for inhibiting tartar formation containing an anionic metal ion sequestrant and a cationic polymer as an active ingredient.
본 발명의 치석 형성 억제용 구강용 조성물은, 치아 표면의 치석 형성을 효과적으로 방지할 수 있고, 동시에 치약의 향미를 유지하며 기포력을 향상시킬 수 있다.Oral composition for inhibiting tartar formation of the present invention can effectively prevent tartar formation on the surface of the tooth, and at the same time maintain the flavor of the toothpaste and improve the foaming force.
다른 식으로 정의되지 않는 한, 본 명세서에서 사용된 모든 기술적 및 과학적 용어들은 본 발명이 속하는 기술 분야에서 숙련된 전문가에 의해서 통상적으로 이해되는 것과 동일한 의미를 가진다. 일반적으로, 본 명세서에서 사용된 명명법은 본 기술 분야에서 잘 알려져 있고 통상적으로 사용되는 것이다.Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. In general, the nomenclature used herein is well known and commonly used in the art.
본 발명의 시험예에서, 음이온성 금속이온봉쇄제 및 양이온성 고분자를 함유하는 구강용 조성물을 치아모사물질에 처리한 결과, 음이온성 금속이온봉쇄제 및 양이온성 고분자가 코아세르베이트 형태로 치아 표면에 잔류함으로써, 잔류하는 음이온성 금속이온봉쇄제가 치석 형성을 억제하는 효과를 나타내는 것을 확인할 수 있었다. In the test example of the present invention, as a result of treating the oral composition containing the anionic metal ion sequestrant and the cationic polymer to the tooth simulation material, the anionic metal ion sequestrant and the cationic polymer remained on the tooth surface in the form of coacetate. As a result, it was confirmed that the remaining anionic metal ion blocking agent exhibits an effect of suppressing tartar formation.
따라서, 본 발명은 일 관점에서, 음이온성 금속이온봉쇄제 및 양이온성 고분자를 유효성분으로 함유하는 치석 형성 억제용 구강용 조성물에 관한 것이고, 상기 음이온성 금속이온봉쇄제 및 양이온성 고분자는 서로 반응하여 치아 표면에서 코아세르베이트를 형성하는 것을 특징으로 할 수 있다. Accordingly, the present invention relates to an oral composition for inhibiting tartar formation containing an anionic metal ion sequestrant and a cationic polymer as an active ingredient, and the anionic metal ion sequestrant and the cationic polymer react with each other. It can be characterized in that to form coacervate on the tooth surface.
본 발명에 있어서, 상기 조성물은 계면활성제를 더 함유하는 것을 특징으로 할 수 있다.In the present invention, the composition may be characterized in that it further contains a surfactant.
"코아세르베이션(coacervation)"이란, 친수성 콜로이드 용액 속에서, 콜로이드 입자의 수화 감소 및 정전기적 요인에 의해, 분산매에서 농축된 콜로이드졸이 분리되어 가는 현상을 의미하며, 분리된 액상 중에서 한쪽 액상은 콜로이드 농도가 높고, 다른 쪽 액상은 콜로이드 농도가 낮아지게 된다. "코아세르베이트(coacervate)"란 음이온성 고분자 전해질과 양이온성 고분자 전해질이 특정 조건에서 혼합되었을 때의 코아세르베이션 현상으로 인해 형성되는 콜로이드 물질을 의미한다. "Coacervation" refers to a phenomenon in which a colloidal sol concentrated in a dispersion medium is separated from a hydrophilic colloidal solution by a decrease in hydration of the colloidal particles and an electrostatic factor. The colloid concentration is high and the other liquid phase is lower in the colloid concentration. "Coacervate" refers to a colloidal material formed due to coacervation phenomena when anionic polymer electrolyte and cationic polymer electrolyte are mixed under certain conditions.
본 발명의 구강용 조성물에 함유된 음이온성 금속이온봉쇄제는 양이온성 고분자와 이온결합하여 침전함으로써 코아세르베이트를 형성하고, 형성된 코아세르베이트는 치석 형성 억제 효과를 갖는 금속이온봉쇄제가 치아 표면에 오랫동안 잔류할 수 있도록 한다.The anionic metal ion sequestrant contained in the composition for oral cavity of the present invention forms coacervates by ionic bonding with the cationic polymer to precipitate, and the formed coacervates may have a metal ion sequestrant having an effect of inhibiting tartar formation on the tooth surface for a long time. Make sure
본 발명에 있어서, 상기 음이온성 금속이온봉쇄제는 인산(phosphate)계 화합물인 것을 특징으로 할 수 있다. 음이온성 금속이온봉쇄제는 치석 형성에 중요한 영향을 미치는 금속이온을 킬레이팅(chelating)하여 치석 형성을 억제하는 물질로서, 인산계 화합물이 바람직하며, 헥사메타포스페이트(hexametaphosphate), 파이로포스페이트(pyrophosphate), 폴리포스페이트(polyphosphate), 및 이들의 염으로 이루어진 군에서 선택된 1종 이상일 수 있다. 상기 염은 1~4개의 알칼리금속 양이온과 음이온인 포스페이트계 화합물이 결합한 형태일 수 있으며, 구체적인 예로는 소듐 포스페이트(Sodium phosphate), 모노소듐 포스페이트(Monosodium phosphate), 디소듐 포스페이트(Disodium phosphate), 트리소듐 포스페이트(Trisodium phosphate), 소듐 트리폴리포스페이트(Sodium tripolyphosphate), 소듐 헥사메타포스페이트(Sodium hexametaphosphate), 테트라소듐 파이로포스페이트(Tetrasodium pyrophosphate), 소듐 엑시드 파이로포스페이트(Sodium acid pyrophosphate) 등이 있으나, 반드시 이에 한정되는 것은 아니다.In the present invention, the anionic metal ion blocking agent may be characterized in that the phosphate compound. Anionic metal ion sequestrant is a substance that inhibits tartar formation by chelating metal ions which have an important effect on tartar formation. Phosphoric acid-based compounds are preferred, and hexametaphosphate and pyrophosphate. ), Polyphosphate, and salts thereof may be one or more selected from the group consisting of. The salt may be in the form of a combination of 1 to 4 alkali metal cations and an anionic phosphate-based compound, and specific examples thereof include sodium phosphate, monosodium phosphate, disodium phosphate, and tree. Sodium phosphate, Sodium tripolyphosphate, Sodium hexametaphosphate, Tetrasodium pyrophosphate, Sodium acid pyrophosphate, but not necessarily It is not limited.
또한, 본 발명에 있어서, 상기 양이온성 고분자는 폴리쿼터늄(polyquaternium)계 화합물인 것을 특징으로 할 수 있다. 폴리쿼터늄계 화합물은 4차 암모늄 이온이 중심에 존재하는 고분자 화합물(중합체)을 의미하며, 바람직하게는 폴리쿼터늄-10, 폴리쿼터늄-6, 폴리쿼터늄-11로 이루어진 군에서 선택된 1종 이상일 수 있으나, 반드시 이에 한정되는 것은 아니다.In addition, in the present invention, the cationic polymer may be a polyquaternium-based compound. The polyquaternium-based compound refers to a polymer compound (polymer) in which quaternary ammonium ions are present at the center, and preferably one selected from the group consisting of polyquaternium-10, polyquaternium-6, and polyquaternium-11 It may be more than, but is not necessarily limited thereto.
또한, 본 발명에 있어서, 상기 구강용 조성물은 음이온성 금속이온봉쇄제 및 양이온성 고분자 외에도, 계면활성제를 더 함유하는 것을 특징으로 할 수 있다. 계면활성제의 구체적인 예로는, 글리시네이트계, 설페이트계, 설포석시네이트계, 사코시네이트계, 포스페이트계, 이세치오네이트계, 글루타메이트계, 타우레이트계 등의 음이온성 계면활성제나, 베타인, 설타인, 암포아세테이트계 등의 양쪽성 계면활성제, 폴리옥시에틸렌 소르비탄 지방산에스테르, 폴리옥시에틸렌(경화) 피마자유, 글리세린지방산에스테르, 솔비탄지방산에스테르, 자당지방산에스테르, 알킬올아미드, 알킬글루코시드 등의 비이온 계면활성제, N-알킬디아미노 에틸글리신 등의 양이온성 계면활성제 등이 있고, 바람직하게는 소듐 라우릴 설페이트(Sodium lauryl sulfate), 소듐 메칠 코코일 타우레이트(Sodium methyl cocoyl taurate), 및 디소듐 라우릴 설포석시네이트(Disodium lauryl sulfosuccinate)로 이루어진 군에서 선택된 1종 이상일 수 있으나, 반드시 이에 한정되는 것은 아니다.In addition, in the present invention, the composition for oral cavity may further comprise a surfactant, in addition to the anionic metal ion blocking agent and the cationic polymer. Specific examples of the surfactant include anionic surfactants such as glycinate, sulfate, sulfosuccinate, sacosinate, phosphate, isethionate, glutamate, and taurate, and betaine. Amphoteric surfactants such as, steine, ampoacetate, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene (cured) castor oil, glycerin fatty acid ester, sorbitan fatty acid ester, sucrose fatty acid ester, alkylolamide, alkylglucose Nonionic surfactants such as seeds, cationic surfactants such as N-alkyldiamino ethylglycine, and the like, preferably sodium lauryl sulfate and sodium methyl cocoyl taurate , And disodium lauryl sulfosuccinate, but may be one or more selected from the group consisting of It is not limited to this.
또한, 본 발명에 있어서, 상기 음이온성 금속이온봉쇄제는 조성물 총 중량에 대하여 0.1~10.0중량%로 함유될 수 있고, 바람직하게는 1.0~7.0중량%, 더욱 바람직하게는 3.0~5.0중량%로 함유될 수 있다. 상기 음이온성 금속이온봉쇄제의 함량이 0.1중량% 미만이면 코아세르베이트가 형성되지 않고, 10.0중량%를 초과하면 향미와 기포력이 저하되고, 자극감이 심해지는 등 치약 사용감에 있어 좋지 않은 영향을 줄 수 있다.In addition, in the present invention, the anionic metal ion sequestrant may be contained in 0.1 to 10.0% by weight relative to the total weight of the composition, preferably 1.0 to 7.0% by weight, more preferably 3.0 to 5.0% by weight It may be contained. If the content of the anionic metal ion blocker is less than 0.1% by weight, no coacervate is formed. If the content of the anionic metal ion blocker is greater than 10.0% by weight, the flavor and foaming power may be lowered and the irritation may be increased. have.
또한, 상기 양이온성 고분자는 조성물 총 중량에 대하여 0.01~0.50중량%로 함유될 수 있고, 바람직하게는 0.05~0.50중량%, 더욱 바람직하게는 0.10~0.50중량%로 함유될 수 있다. 상기 양이온성 고분자의 함량이 0.01중량% 미만이면 코아세르베이트가 형성되지 않고, 0.50중량%를 초과하면 치약내 점도가 높아 사용하기에 불편할 수 있다.In addition, the cationic polymer may be contained in an amount of 0.01 to 0.50% by weight based on the total weight of the composition, preferably 0.05 to 0.50% by weight, more preferably 0.10 to 0.50% by weight. If the content of the cationic polymer is less than 0.01% by weight coacetate is not formed, if the content exceeds 0.50% by weight it may be inconvenient to use the high viscosity in the toothpaste.
또한, 본 발명에 있어서, 상기 음이온성 금속이온봉쇄제와 양이온성 고분자는 0.2:1~1000:1의 중량비로 혼합되어 함유될 수 있고, 바람직하게는 10:1~100:1, 더욱 바람직하게는 30:1~50:1의 중량비로 혼합되어 함유될 수 있다. 음이온성 금속이온봉쇄제의 분자량이 상대적으로 작기 때문에, 양이온성 고분자보다 높은 비율로 혼합하는 것이 바람직하다. 상기 음이온성 금속이온봉쇄제와 양이온성 고분자의 혼합 비율이 0.2:1 미만이거나 1000:1 초과이면 코아세르베이트가 형성되기 어려울 수 있다.In addition, in the present invention, the anionic metal ion blocking agent and the cationic polymer may be mixed and contained in a weight ratio of 0.2: 1 to 1000: 1, preferably 10: 1 to 100: 1, more preferably May be mixed in a weight ratio of 30: 1 to 50: 1. Since the molecular weight of the anionic metal ion blocking agent is relatively small, it is preferable to mix at a higher ratio than the cationic polymer. If the mixing ratio of the anionic metal ion blocking agent and the cationic polymer is less than 0.2: 1 or more than 1000: 1, coacervate may be difficult to form.
본 발명의 구강용 조성물은 그 제형에 있어서 특별히 한정되지 않으며, 구체적인 예를 들면, 치약, 구강용 세정제, 구강용 청정제, 껌, 캔디류, 구강스프레이, 구강양치액, 치아 미백제 등의 제형을 가질 수 있다.The composition for oral cavity of this invention is not specifically limited in the formulation, For example, Toothpaste, Oral detergent, Oral detergent, Chewing gum, Candy, Oral spray, Oral toothpaste, A tooth whitening agent, etc. can be provided. .
본 발명의 구강용 조성물은 제형 및 사용 목적에 따라 통상적으로 사용하는 연마제, 습윤제, 보조 기포제, 결합제, 감미제, pH 조절제, 방부제, 약효성분, 향료, 증백제, 색소, 용제 등을 함유할 수 있다.The composition for oral cavity of the present invention may contain abrasives, wetting agents, auxiliary foaming agents, binders, sweeteners, pH adjusting agents, preservatives, active ingredients, fragrances, brighteners, pigments, solvents and the like which are commonly used according to the formulation and purpose of use. .
상기 연마제로는 침강실리카, 실리카겔, 지르코늄실리케이트, 인산일수소칼슘, 무수인산일수소칼슘, 함수알루미나, 경질탄산칼슘, 중질탄산칼슘, 칼슘피로인산염, 불용성메타인산염, 알루미늄실리케이트 등을 사용할 수 있다.As the abrasive, precipitated silica, silica gel, zirconium silicate, calcium monohydrogen phosphate, calcium monohydrogen phosphate, hydrous alumina, hard calcium carbonate, heavy calcium carbonate, calcium pyrophosphate, insoluble methphosphate, aluminum silicate and the like can be used.
상기 습윤제로는 농글리세린, 글리세린, 소르비톨수용액, 비결정성 소르비톨수용액, 폴리에틸렌글리콜류, 프로필렌글리콜 등을 사용할 수 있다.As the wetting agent, concentrated glycerin, glycerin, aqueous sorbitol solution, amorphous sorbitol aqueous solution, polyethylene glycols, propylene glycol and the like can be used.
상기 보조 기포제로는 알킬황산나트륨, 라우릴 황산나트륨, 자당지방산에스테르, 소르비탄지방산에스테르 등의 음이온 및 비이온 계면 활성제를 사용할 수 있다.As the auxiliary foaming agent, anionic and nonionic surfactants such as sodium alkyl sulfate, sodium lauryl sulfate, sucrose fatty acid ester, and sorbitan fatty acid ester may be used.
상기 결합제로는 카르복시메틸셀룰로오스나트륨, 카라기난, 잔탄검, 히드록시에틸셀룰로오스, 히드록시프로필메틸셀룰로오스, 히드록시프로필셀룰로오스, 구아검, 젤란검, 카보머, 펙틴, 폴리비닐피롤리돈, 카르복시비닐폴리머, 알긴산나트륨, 라포나이트, 카르복시메틸셀룰로오스나트륨, 잔탄검 등을 사용할 수 있다.The binder is sodium carboxymethyl cellulose, carrageenan, xanthan gum, hydroxyethyl cellulose, hydroxypropylmethylcellulose, hydroxypropyl cellulose, guar gum, gellan gum, carbomer, pectin, polyvinylpyrrolidone, carboxyvinyl polymer Sodium alginate, laponite, sodium carboxymethylcellulose, xanthan gum and the like can be used.
상기 감미제로는 삭카린나트륨, 수크랄로스, 말티톨, 아스파탐, 에리스리톨, 자일리톨, 감초산, 사카린나트륨 등을 사용할 수 있고, 상기 방부제로는 안식향산, 메틸파라벤, 프로필파라벤, 안식향산나트륨, 파라옥시안식향산에스테르 등을 사용할 수 있다. 또한, 상기 향료로는 페퍼민트 오일, 스페아민트 오일, 멘톨 등을 단독 또는 혼합하여 사용할 수 있고, 상기 pH 조절제로는 인산나트륨, 인산이나트륨, 구연산, 트리에탄올아민 등을 사용할 수 있다.Examples of the sweetener include saccharin sodium, sucralose, maltitol, aspartame, erythritol, xylitol, licorice acid, saccharin, and the like. The preservatives include benzoic acid, methylparaben, propylparaben, sodium benzoate, paraoxybenzoic acid ester, and the like. Can be used. In addition, the fragrance may be used alone or mixed with peppermint oil, spearmint oil, menthol, etc., the pH adjuster may be used sodium phosphate, disodium phosphate, citric acid, triethanolamine and the like.
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 예시하기 위한 것으로, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지 않는 것은 당업계에서 통상의 지식을 가진 자에게 있어서 자명할 것이다. 따라서 본 발명의 실질적인 범위는 첨부된 청구항들과 그것들의 등가물에 의하여 정의된다고 할 것이다.Hereinafter, the present invention will be described in more detail with reference to Examples. These examples are only for illustrating the present invention, and it will be apparent to those skilled in the art that the scope of the present invention is not to be construed as being limited by these examples. Thus, the substantial scope of the present invention will be defined by the appended claims and their equivalents.
[실시예 1~9 및 비교예 1~3의 제조][Manufacture of Examples 1-9 and Comparative Examples 1-3]
본 발명의 구강용 조성물의 코아세르베이트 생성 정도 및 잔류 정도를 테스트하기 위해, 정제수, 음이온성 금속이온봉쇄제(소듐헥사메타포스페이트, 테트라소듐파이로포스페이트, 소듐트리폴리포스페이트), 양이온성 고분자(폴리쿼터늄-10, 폴리쿼터늄-6, 폴리쿼터늄-11), 계면활성제(소듐라우릴설페이트, 소듐메칠코코일타우레이트, 디소늄라우릴설포석시네이트)를 주요 구성성분으로 하여, 하기 표 1의 구성과 같이 실시예 1 내지 9, 및 비교예 1 내지 3을 각각 총 중량이 100g이 되도록 제조하였다.In order to test the degree of coacervate formation and residual degree of the oral composition of the present invention, purified water, anionic metal ion blocker (sodium hexametaphosphate, tetrasodium pyrophosphate, sodium tripolyphosphate), cationic polymer (polyquaternium -10, polyquaternium-6, polyquaternium-11), surfactant (sodium lauryl sulfate, sodium methyl cocoyl taurate, dissonium lauryl sulfosuccinate) as the main components, Examples 1 to 9, and Comparative Examples 1 to 3, respectively, were prepared to have a total weight of 100 g as in the configuration.
(단위: 중량%)(Unit: weight%)
비교예1Comparative Example 1 비교예2Comparative Example 2 비교예3Comparative Example 3 실시예1Example 1 실시예2Example 2 실시예3Example 3 실시예4Example 4 실시예5Example 5 실시예6Example 6 실시예7Example 7 실시예8Example 8 실시예9Example 9
정제수Purified water To 100To 100 To 100To 100 To 100To 100 To100To100 To100To100 To100To100 To100To100 To 100To 100 To100To100 To100To100 To100To100 To100To100
소듐헥사메타포스페이트Sodium hexametaphosphate 33 0.50.5 77 33 33 -- -- 33 33 33 33 55
테트라소듐파이로포스페이트Tetrasodium pyrophosphate -- -- -- -- -- 33 -- -- -- -- -- --
소듐트리폴리포스페이트Sodium tripolyphosphate -- -- -- -- -- -- 33 -- -- -- -- --
폴리쿼터늄-10Polyquaternium-10 -- 0.10.1 0.10.1 0.10.1 0.10.1 0.10.1 0.10.1 -- -- 0.10.1 0.10.1 0.10.1
폴리쿼터늄-6Polyquaternium-6 -- -- -- -- -- -- -- 0.10.1 -- -- -- --
폴리쿼터늄-11Polyquaternium-11 -- -- -- -- -- -- -- -- 0.10.1 -- -- --
소듐 라우릴설페이트Sodium lauryl sulfate 22 22 22 -- 22 22 22 22 22 -- -- 22
소듐 메칠 코코일타우레이트Sodium methyl cocoyl taurate -- -- -- -- -- -- -- -- -- 22 -- --
디소듐 라우릴설포석시네이트Disodium laurylsulfosuccinate -- -- -- -- -- -- -- -- -- -- 22 --
[시험예 1] 코아세르베이트 생성 정도 측정Test Example 1 Coacervate Formation Measurement
실시예 1 내지 9 및 비교예 1 내지 3의 샘플을 취하여, 각각에 정제수 첨가 비율을 점차 높이고, 샘플의 비율은 점차 낮추어가며 하기 표 2에 나타난 바와 같이 희석비율을 조정하되, 총 중량은 3g을 유지하도록 하였다. UV spectroscopy를 이용하여 희석된 각 샘플의 투명도(%)를 측정한 후, 그 결과를 표 2에 나타내었다. 투명도가 낮을수록 코아세르베이트가 많이 형성된 것으로 판단하였다.Take samples of Examples 1 to 9 and Comparative Examples 1 to 3, and gradually increase the ratio of purified water added to each, and gradually decrease the ratio of the sample, and adjust the dilution ratio as shown in Table 2 below, but the total weight is 3 g. To maintain. After measuring the transparency (%) of each diluted sample using UV spectroscopy, the results are shown in Table 2. The lower the transparency, the more coacervates were determined.
2배 희석2-fold dilution 5배희석5x 10배희석10 times 20배희석20 times 40배희석40x
샘플의 양(g)Amount of sample (g) 1.51.5 0.60.6 0.30.3 0.150.15 0.080.08
정제수의 양(g)Amount of purified water (g) 1.51.5 2.42.4 2.72.7 2.852.85 2.932.93
투명도(%)transparency(%)
비교예 1Comparative Example 1 100%100% 100%100% 100%100% 100%100% 100%100%
비교예 2Comparative Example 2 99%99% 95%95% 90%90% 95%95% 99%99%
비교예 3Comparative Example 3 99%99% 90%90% 85%85% 88%88% 99%99%
실시예 1Example 1 100%100% 99%99% 76%76% 84%84% 92%92%
실시예 2Example 2 95%95% 30%30% 54%54% 84%84% 98%98%
실시예 3Example 3 99%99% 80%80% 85%85% 96%96% 99%99%
실시예 4Example 4 96%96% 35%35% 58%58% 88%88% 98%98%
실시예 5Example 5 92%92% 11%11% 36%36% 61%61% 75%75%
실시예 6Example 6 99%99% 98%98% 77%77% 83%83% 94%94%
실시예 7Example 7 90%90% 20%20% 44%44% 74%74% 88%88%
실시예 8Example 8 92%92% 24%24% 43%43% 77%77% 90%90%
실시예 9Example 9 92%92% 25%25% 40%40% 64%64% 90%90%
상기 표 2에 나타난 바와 같이, 양이온성 고분자를 함유하지 않은 비교예 1의 경우 코아세르베이트가 형성되지 않았고, 음이온성 금속이온봉쇄제와 함께 양이온성 고분자를 함유하나, 계면활성제를 함유하지 않는 실시예 1의 경우, 희석 조건에 따라 코아세르베이트 생성 정도의 차이를 보였다. 또한, 음이온성 금속이온봉쇄제, 양이온성 고분자, 및 계면활성제를 함유하는 용액이 희석됨에 따라 코아세르베이트가 더 많이 형성되다가 어느 지점을 넘어서면 다시 코아세르베이트가 형성되지 않는 것을 확인할 수 있었다. 이로부터, 코아세르베이트 형성을 위해서는 적절한 희석비율이 중요함을 확인할 수 있었다.As shown in Table 2, in Comparative Example 1 containing no cationic polymer, coacetate was not formed, and Example 1 containing a cationic polymer together with an anionic metal ion sequestrant, but no surfactant. In the case of the dilution conditions showed a difference in the degree of coacervate production. In addition, as the solution containing the anionic metal ion sequestrant, the cationic polymer, and the surfactant was diluted, more coacetate was formed, and it was confirmed that coacervate was not formed again after a certain point. From this, it could be confirmed that the proper dilution ratio is important for coacervate formation.
또한, 음이온성 금속이온봉쇄제 및 양이온성 고분자와 함께, 치약 제형에서 필수요소인 기포 형성을 위한 계면활성제를 첨가한 경우, 양이온성 고분자의 종류(실시예 2, 5, 6 비교), 음이온성 금속이온봉쇄제의 종류(실시예 2, 3, 4 비교), 또는 계면활성제의 종류(실시예 2, 7, 8 비교)에 따라서 코아세르베이트 생성 정도에 차이가 있음을 확인할 수 있었고, 음이온성 금속이온봉쇄제의 함량(실시예 2, 9 비교)에 따라서도 코아세르베이트 생성 정도에 차이가 생기는 것을 확인할 수 있었다.In addition, in addition to the anionic metal ion blocking agent and the cationic polymer, when a surfactant for foam formation, which is an essential element in the toothpaste formulation, is added, the type of cationic polymer (compare Examples 2, 5, 6), anionic It was confirmed that there was a difference in the degree of coacervate production depending on the type of the metal ion blocking agent (compare Examples 2, 3, 4) or the type of the surfactant (compare Examples 2, 7, 8), and anionic metal ion According to the content of the blocking agent (compare Examples 2, 9) it was confirmed that the difference in the degree of coacetate production.
또한, 실시예 1 내지 9에 비해 음이온성 금속이온봉쇄제 및 양이온성 고분자의 혼합비율(중량비)이 30:1 보다 낮은 비교예 2나, 50:1 보다 높은 비교예 3의 경우, 30:1~50:1의 범위 내에 있는 실시예 1 내지 9에 비해 코아세르베이트가 잘 생성되지 않음을 알 수 있었다.In addition, compared to Examples 1 to 9, the mixing ratio (weight ratio) of the anionic metal ion sequestering agent and the cationic polymer is 30: 1 in Comparative Example 2 lower than 30: 1, or in Comparative Example 3 higher than 50: 1, It was found that coacervates were not produced well compared to Examples 1 to 9 in the range of ˜50: 1.
[시험예 2] 치아 표면의 금속이온봉쇄제 잔류량 측정Test Example 2 Measurement of Residual Amount of Metal Ion Blocker on Teeth Surface
상기 시험예 1에서 음이온성 금속이온봉쇄제, 양이온성 고분자, 및 계면활성제가 함유된 용액에서 코아세르베이트가 형성되는 것을 확인한 후, 형성된 코아세르베이트가 얼마나 치아 표면에 잔류하는지를 생체외 테스트(in vitro test)를 통해 측정하였다. In Example 1, after confirming that coacervate is formed in a solution containing an anionic metal ion sequestrant, a cationic polymer, and a surfactant, an in vitro test is performed to determine how much coacervate formed remains on the tooth surface. Measured through.
표 1과 같이 제조된 실시예 2, 7, 9 및 비교예 1의 용액을 10배 희석한 후, 치아모사물질인 하이드록시아파타이트 디스크(Clarkson Chromatography Products)에 자동칫솔질 기계인 V-8 크로스 브러싱 머신(V-8 Cross Brushing Machine®, Sabri, USA)을 이용하여 브러싱을 하였다. 하이드록시아파타이트 디스크간의 오차를 줄이기 위해 4개의 디스크를 사용하였고, 3분간 희석용액을 브러싱 머신으로 양치질을 구현한 후 5회 세척하였다. 이를 10회 반복한 후 하이드록시아파타이트에 부착된 코아세르베이트를 수산화나트륨 용액(0.3M)으로 녹인 후, 이온크로마토그래피법(Ion chromatography, Metrohm)을 이용하여 코아세르베이트 내에 잔류하는 음이온성 금속이온봉쇄제의 양을 측정한 결과를 표 3에 나타내었다. After diluting 10 times the solution of Examples 2, 7, 9 and Comparative Example 1 prepared as shown in Table 1, V-8 cross brushing machine which is an automatic brushing machine on hydroxyapatite disk (Clarkson Chromatography Products) Brushing was performed using (V-8 Cross Brushing Machine®, Sabri, USA). Four disks were used to reduce the error between the hydroxyapatite disks, and the diluted solution was brushed with a brushing machine for 5 minutes, and then washed five times. After repeating this ten times, the coacervate attached to the hydroxyapatite was dissolved in sodium hydroxide solution (0.3M), and the amount of the anionic metal ion sequestrant remaining in the coacervate using ion chromatography (Meon chromatography, Metrohm). The results of the measurement are shown in Table 3.
(단위: ppm)(Unit: ppm)
디스크 1Disc 1 디스크 2Disc 2 디스크 3Disc 3 디스크 4Disc 4 평균(ppm)Average (ppm)
비교예 1Comparative Example 1 2.602.60 4.304.30 2.232.23 2.22.2 2.832.83
실시예 2Example 2 18.1318.13 29.4229.42 12.3012.30 14.0514.05 18.4818.48
실시예 7Example 7 16.6116.61 25.1025.10 22.4022.40 20.5020.50 21.1521.15
실시예 9Example 9 35.1235.12 30.2230.22 33.3533.35 36.3636.36 33.7633.76
상기 표 3에 나타난 바와 같이, 양이온성 고분자가 없는 경우(비교예 1)보다 양이온성 고분자가 있는 경우(실시예 2, 7, 9) 음이온성 금속이온봉쇄제의 잔류량이 확연히 많음을 알 수 있었고, 계면활성제간 차이는 약간 있지만 크지 않았으며(실시예 2, 7 비교), 음이온성 금속이온봉쇄제의 함량이 증가된 경우에는 음이온성 금속이온봉쇄제의 잔류량이 유의적으로 증가함(실시예 2, 9 비교)을 확인할 수 있었다. As shown in Table 3, when there is a cationic polymer (Examples 2, 7, 9) than when there is no cationic polymer (Comparative Example 1), it was found that the residual amount of the anionic metal ion sequestrant was significantly higher. , The difference between the surfactants was slightly but not large (compare Examples 2 and 7), and when the amount of the anionic metal ion sequestrant increased, the residual amount of the anionic metal ion sequestrant increased significantly (Example 2, 9 comparison) could be confirmed.
[실시예 10~11 및 비교예 4의 제조][Manufacture of Examples 10-11 and Comparative Example 4]
음이온성 금속이온봉쇄제 및 양이온성 고분자를 함유하는 코아세르베이트 용액을 치약 형태의 페이스트 제형에 함유시킨 실시예 10~11 및 비교예 4를 하기 표 4의 구성과 같이 제조하였다.Examples 10 to 11 and Comparative Example 4 in which a coacervate solution containing an anionic metal ion blocking agent and a cationic polymer were included in a paste formulation in the form of a toothpaste were prepared as shown in Table 4 below.
(단위: 중량%)(Unit: weight%)
구분division 성분명Ingredient Name 비교예4Comparative Example 4 실시예10Example 10 실시예11Example 11
용제solvent 정제수Purified water To 100To 100 To 100To 100 To 100To 100
금속이온봉쇄제Metal Ion Blocker 소듐헥사메타포스페이트Sodium hexametaphosphate 33 33 55
양이온고분자Cationic polymer 폴리쿼터늄-10Polyquaternium-10 -- 0.10.1 0.10.1
유효성분Active ingredient 일불소인산나트륨Sodium monofluorophosphate 0.760.76 0.760.76 0.760.76
습윤제Humectant 소르비톨액 (70%)Sorbitol Liquid (70%) 5050 5050 5050
감미제Sweetener 소듐 사카린Sodium saccharin 0.40.4 0.40.4 0.40.4
연마제abrasive 실리카Silica 1010 1010 1010
점증제Thickener 하이드록시메칠셀룰로오즈Hydroxymethylcellulose 1.51.5 1.51.5 1.51.5
향료Spices 조합향료Combination spices 1One 1One 1One
기포제Foam 소듐라우릴설페이트Sodium lauryl sulfate 22 22 22
[시험예 3] 치석형성 억제효능 측정[Test Example 3] Measurement of plaque formation inhibitory effect
시험예 1 및 시험예 2의 결과를 바탕으로, 음이온성 금속이온봉쇄제 및 양이온성 고분자를 함유하는 본 발명의 구강용 조성물이 치석 형성을 억제하는 효능을 갖는지 측정하였다. Based on the results of Test Example 1 and Test Example 2, it was determined whether the composition for oral cavity of the present invention containing an anionic metal ion blocking agent and a cationic polymer has an effect of inhibiting tartar formation.
먼저, 사포질한 유리막대를 패널로부터 얻은 침과 설탕을 첨가한 용액에 담근 후, 2일간 35도에서 숙성시켰다. 유리막대 표면에 프라그를 형성시킨 후 25%의 치약 슬러리 용액(비교예 4, 실시예 10, 11)과 칼슘클로라이드(1.5mM)로 구성된 결정화 용액에 유리막대를 담궈 밤새 보관한 후 다음 날 5초간 유리막대 세척 후 다시 치약 슬러리 용액과 결정화 용액에 담궈 보관하였다. 이를 2주간 반복하여 형성된 치석을 강산(1M HCl)과 강염기(1M KOH)로 녹인 후 이온크로마토그래피(Ion chromatography, Metrohm)를 이용하여 칼슘 함량을 분석하여, 그 결과를 하기 표 5에 나타내었다. 칼슘함량이 낮을수록 치석 형성 억제 능력이 좋다고 판단하였다. First, the sanded glass rod was immersed in a solution added with saliva and sugar obtained from the panel, and then aged at 35 degrees for 2 days. After forming plaque on the surface of the glass rod, the glass rod was immersed in a crystallization solution consisting of 25% toothpaste slurry solution (Comparative Examples 4, 10 and 11) and calcium chloride (1.5 mM) and stored overnight for 5 seconds. After washing the glass rod, it was stored again in the toothpaste slurry solution and crystallization solution. The tartar formed by repeating this for two weeks was dissolved in strong acid (1M HCl) and strong base (1M KOH) and analyzed by calcium content using ion chromatography (Ion chromatography, Metrohm). The results are shown in Table 5 below. It was judged that the lower the calcium content, the better the ability to inhibit tartar formation.
비교예4Comparative Example 4 실시예10Example 10 실시예11Example 11
유리막대 4개에서 추출한 칼슘 평균 함량 (μg)Average content of calcium extracted from 4 glass rods (μg) 857857 608608 532532
칼슘 함량 분석 결과, 표 5에 나타난 바와 같이, 양이온성 고분자를 함유한 경우(실시예 10, 11), 함유하지 않은 경우(비교예 4)보다 칼슘 함량이 낮고, 음이온성 금속이온봉쇄제의 함량을 증가시킬수록(실시예 10, 11 비교) 칼슘 함량이 낮아지는 것을 확인할 수 있었다. As a result of the calcium content analysis, as shown in Table 5, the content of anionic metal ion blocking agent is lower than that of the case of containing a cationic polymer (Examples 10 and 11), and of the case of not containing (Comparative Example 4). Increasing the (Comparative Example 10, 11) was confirmed that the calcium content is lowered.
[시험예 4] 치약 사용감 평가[Test Example 4] toothpaste feeling evaluation
시험예 3의 치석 형성 억제력 측정 결과를 바탕으로, 치약의 사용감을 평가하였다. 상기 실시예 10, 실시예 11, 및 비교예 4를 각각 20명씩 사용하게 하였고, 2주 사용 후 설문 조사를 통해 향미, 기포력, 자극감, 전체적인 만족도를 평가하게 한 후, 그 결과를 표 6에 나타내었다. Based on the measurement results of calculus formation inhibitory power of Test Example 3, the feeling of use of the toothpaste was evaluated. Each of Example 10, Example 11, and Comparative Example 4 were used by 20 people, and after two weeks of use, a survey was conducted to evaluate flavor, foaming power, stimulus, and overall satisfaction, and the results are shown in Table 6 below. Indicated.
구분division 비교예4Comparative Example 4 실시예10Example 10 실시예11Example 11
향미Flavor 3.53.5 3.33.3 3.63.6
기포력Bubble 3.73.7 4.24.2 4.04.0
자극감Irritation 4.04.0 3.93.9 3.93.9
전제적인 만족도Total satisfaction 3.53.5 3.73.7 3.63.6
(1점 : 매우 불만족 / 2점 : 불만족 / 3점 : 보통 / 4점 : 만족 / 5점 : 매우 만족)(1 point: very dissatisfied / 2 points: dissatisfied / 3 points: normal / 4 points: satisfactory / 5 points: very satisfied)
표 6에 나타난 바와 같이, 양이온성 고분자가 함유된 조성물(실시예 10, 11)이 치약의 향미 및 자극감에 커다란 영향을 주지 않았고, 기포력에 있어서는 오히려 도움을 주는 것을 확인할 수 있었다.As shown in Table 6, it was confirmed that the composition containing the cationic polymer (Examples 10 and 11) did not significantly affect the flavor and irritation of the toothpaste, and rather helped in foaming power.
이상으로 본 발명 내용의 특정한 부분을 상세히 기술하였는바, 당업계의 통상의 지식을 가진 자에게 있어서 이러한 구체적 기술은 단지 바람직한 실시태양일 뿐이며, 이에 의해 본 발명의 범위가 제한되는 것이 아닌 점은 명백할 것이다. 따라서, 본 발명의 실질적인 범위는 첨부된 청구항들과 그것들의 등가물에 의하여 정의된다고 할 것이다.The specific parts of the present invention have been described in detail above, and it is apparent to those skilled in the art that such specific descriptions are merely preferred embodiments, and thus the scope of the present invention is not limited thereto. something to do. Thus, the substantial scope of the present invention will be defined by the appended claims and their equivalents.

Claims (11)

  1. 음이온성 금속이온봉쇄제 및 양이온성 고분자를 유효성분으로 함유하는 치석 형성 억제용 구강용 조성물.Oral composition for inhibiting tartar formation containing an anionic metal ion blocking agent and a cationic polymer as an active ingredient.
  2. 제1항에 있어서, 상기 음이온성 금속이온봉쇄제 및 양이온성 고분자는 서로 반응하여 치아 표면에서 코아세르베이트(coacervate)를 형성하는 것을 특징으로 하는 구강용 조성물.The oral composition of claim 1, wherein the anionic metal ion sequestrant and the cationic polymer react with each other to form coacervate on the tooth surface.
  3. 제1항에 있어서, 상기 구강용 조성물은 계면활성제를 더 함유하는 것을 특징으로 하는 구강용 조성물.The oral composition according to claim 1, wherein the oral composition further contains a surfactant.
  4. 제1항에 있어서, 상기 음이온성 금속이온봉쇄제는 인산(phosphate)계 화합물인 것을 특징으로 하는 구강용 조성물.The oral composition of claim 1, wherein the anionic metal ion sequestrant is a phosphate compound.
  5. 제1항에 있어서, 상기 양이온성 고분자는 폴리쿼터늄(polyquaternium)계 화합물인 것을 특징으로 하는 구강용 조성물.The composition for oral cavity of claim 1, wherein the cationic polymer is a polyquaternium-based compound.
  6. 제3항에 있어서, 상기 계면활성제는 소듐 라우릴 설페이트(Sodium lauryl sulfate), 소듐 메칠 코코일 타우레이트(Sodium methyl cocoyl taurate), 및 디소듐 라우릴 설포석시네이트(Disodium lauryl sulfosuccinate)로 이루어진 군에서 선택된 어느 1종 이상인 것을 특징으로 하는 구강용 조성물.The group of claim 3, wherein the surfactant is composed of sodium lauryl sulfate, sodium methyl cocoyl taurate, and disodium lauryl sulfosuccinate. Oral composition, characterized in that at least one selected from.
  7. 제4항에 있어서, 상기 인산(phosphate)계 화합물은 헥사메타포스페이트, 파이로포스페이트, 폴리포스페이트, 및 이들의 염으로 이루어진 군에서 선택된 어느 1종 이상인 것을 특징으로 하는 구강용 조성물.The composition for oral cavity according to claim 4, wherein the phosphate-based compound is any one or more selected from the group consisting of hexametaphosphate, pyrophosphate, polyphosphate, and salts thereof.
  8. 제5항에 있어서, 상기 폴리쿼터늄(polyquaternium)계 화합물은 폴리쿼터늄-10, 폴리쿼터늄-6, 및 폴리쿼터늄-11로 이루어진 군에서 선택된 어느 1종 이상인 것을 특징으로 하는 구강용 조성물.The composition for oral cavity of claim 5, wherein the polyquaternium-based compound is any one or more selected from the group consisting of polyquaternium-10, polyquaternium-6, and polyquaternium-11. .
  9. 제1항에 있어서, 상기 음이온성 금속이온봉쇄제는 조성물 총 중량에 대하여 0.1~10.0중량%로 함유되는 것을 특징으로 하는 구강용 조성물.The composition for oral cavity of claim 1, wherein the anionic metal ion sequestrant is contained in an amount of 0.1 to 10.0 wt% based on the total weight of the composition.
  10. 제1항에 있어서, 상기 양이온성 고분자는 조성물 총 중량에 대하여 0.01~0.50중량%로 함유되는 것을 특징으로 하는 구강용 조성물.The composition for oral cavity according to claim 1, wherein the cationic polymer is contained in an amount of 0.01 to 0.50% by weight based on the total weight of the composition.
  11. 제1항에 있어서, 상기 음이온성 금속이온봉쇄제와 양이온성 고분자는 0.2:1~1000:1의 중량비로 혼합되어 함유되는 것을 특징으로 하는 구강용 조성물.The composition for oral cavity of claim 1, wherein the anionic metal ion sequestrant and the cationic polymer are mixed in a weight ratio of 0.2: 1 to 1000: 1.
PCT/KR2015/012470 2015-03-20 2015-11-19 Oral composition effective in inhibiting calculus formation WO2016153144A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201580075837.5A CN107205892B (en) 2015-03-20 2015-11-19 Oral composition effective in inhibiting tartar formation

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR10-2015-0038730 2015-03-20
KR20150038730 2015-03-20
KR1020150162289A KR102406001B1 (en) 2015-03-20 2015-11-19 Oral composition for effective prevention of calculus formation
KR10-2015-0162289 2015-11-19

Publications (1)

Publication Number Publication Date
WO2016153144A1 true WO2016153144A1 (en) 2016-09-29

Family

ID=56977814

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2015/012470 WO2016153144A1 (en) 2015-03-20 2015-11-19 Oral composition effective in inhibiting calculus formation

Country Status (1)

Country Link
WO (1) WO2016153144A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11576947B2 (en) * 2019-03-25 2023-02-14 Kunming Lanchie Dental Hospital, Ltd. Oral composition and method

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994016673A1 (en) * 1993-01-19 1994-08-04 The Gillette Company Mouthrinse
US20050196354A1 (en) * 2004-03-03 2005-09-08 Andre Soshinsky Film compositions
US20090214628A1 (en) * 2004-09-27 2009-08-27 De Rijk Jan Methods and compositions for treatment of skin
EP2476406A2 (en) * 2010-12-08 2012-07-18 Henkel AG & Co. KGaA Oral and tooth care and cleaning agents with improved antibacterial effect II
US20150071977A1 (en) * 2010-04-28 2015-03-12 The Procter & Gamble Company Delivery Particle

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994016673A1 (en) * 1993-01-19 1994-08-04 The Gillette Company Mouthrinse
US20050196354A1 (en) * 2004-03-03 2005-09-08 Andre Soshinsky Film compositions
US20090214628A1 (en) * 2004-09-27 2009-08-27 De Rijk Jan Methods and compositions for treatment of skin
US20150071977A1 (en) * 2010-04-28 2015-03-12 The Procter & Gamble Company Delivery Particle
EP2476406A2 (en) * 2010-12-08 2012-07-18 Henkel AG & Co. KGaA Oral and tooth care and cleaning agents with improved antibacterial effect II

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11576947B2 (en) * 2019-03-25 2023-02-14 Kunming Lanchie Dental Hospital, Ltd. Oral composition and method

Similar Documents

Publication Publication Date Title
RU2603488C2 (en) Oral care compositions
CN108210351A (en) Oral care composition and application method
CN108024916A (en) Oral care composition and application method
US11931437B2 (en) Silica abrasives with high stannous fluoride compatibility
EA038047B1 (en) Toothpaste composition
RU2714131C2 (en) Oral care composition containing zinc salts and calcium carbonate
KR102406001B1 (en) Oral composition for effective prevention of calculus formation
US8580234B2 (en) Method for removing solid product formed on surfaces of teeth
WO2016153144A1 (en) Oral composition effective in inhibiting calculus formation
CN108289804A (en) Metal amino acid complex for bacterial accumulation
TWI552766B (en) Oral care composition
JP6471407B2 (en) Oral or throat composition
JP2004123684A (en) Dentifrice composition
KR20180113471A (en) Dentifrice composition
JP3894110B2 (en) Whitening dentifrice composition
US20170348213A1 (en) Oral Care Composition
CN110769801A (en) Oral care compositions
JPH07126131A (en) Oral cavity composition
US20220031598A1 (en) Oral Care Compositions Containing Abrasives and Cocamidopropyl Betaine
US9326922B2 (en) Oral care compositions containing high purity barium sulfate particles
JP3862006B2 (en) Method for preventing discoloration over time of oral composition and water-soluble polyphosphate-containing oral composition
KR101502025B1 (en) Toothpaste composition for removing tooth stains
JPH05163126A (en) Composition for oral cavity
KR101497061B1 (en) Composition for cleaning the oral
JP2021001152A (en) Liquid oral composition

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15886590

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15886590

Country of ref document: EP

Kind code of ref document: A1